{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:56:16Z","timestamp":1783482976017,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["30EYO22589"],"award-info":[{"award-number":["30EYO22589"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ajo.2022.06.013","type":"journal-article","created":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T01:50:45Z","timestamp":1656121845000},"page":"181-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Effect of Thermoelectric Warming Therapy for the Treatment of Meibomian Gland Dysfunction"],"prefix":"10.1016","volume":"242","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2908-8096","authenticated-orcid":false,"given":"MARIA-LAURA","family":"GOMEZ","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NATALIE A.","family":"AFSHARI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DAISY D.","family":"GONZALEZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LINGYUN","family":"CHENG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2022.06.013_bib0001","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2147\/OPTH.S5555","article-title":"Etiology, prevalence, and treatment of dry eye disease","volume":"3","author":"Gayton","year":"2009","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2022.06.013_bib0002","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.ajo.2022.06.013_bib0003","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II management and therapy report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.ajo.2022.06.013_bib0004","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/bjophthalmol-2018-313267","article-title":"Punctal occlusion for dry eye syndrome: summary of a Cochrane systematic review","volume":"103","author":"Ervin","year":"2019","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2022.06.013_bib0005","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/jop.2019.0060","article-title":"The immunological basis of dry eye disease and current topical treatment options","volume":"36","author":"Periman","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.ajo.2022.06.013_bib0006","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ophtha.2013.09.015","article-title":"Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study","volume":"121","author":"Sheppard","year":"2014","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2022.06.013_bib0007","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/01.iio.0000212137.85298.98","article-title":"Integrating restasis into the management of dry eye","volume":"46","author":"Pflugfelder","year":"2006","journal-title":"Int Ophthalmol Clin"},{"issue":"9","key":"10.1016\/j.ajo.2022.06.013_bib0008","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.ophtha.2019.03.050","article-title":"A phase 3, randomized, double-masked study of OTX-101 ophthalmic solution 0.09% in the treatment of dry eye disease","volume":"126","author":"Goldberg","year":"2019","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2022.06.013_bib0009","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jtos.2017.01.006","article-title":"Emerging strategies for the diagnosis and treatment of meibomian gland dysfunction: Proceedings of the OCEAN group meeting","volume":"15","author":"Geerling","year":"2017","journal-title":"Ocul Surf"},{"issue":"5","key":"10.1016\/j.ajo.2022.06.013_bib0010","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/ICO.0b013e318225415a","article-title":"Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study","volume":"31","author":"Lemp","year":"2012","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ajo.2022.06.013_bib0011","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1167\/iovs.10-6997e","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD","volume":"52","author":"Schaumberg","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2022.06.013_bib0012","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/ICO.0000000000001476","article-title":"Prevalence of meibomian gland atrophy in a pediatric population","volume":"37","author":"Gupta","year":"2018","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.ajo.2022.06.013_bib0013","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.ajo.2022.06.013_bib0014","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/ICU.0000000000000165","article-title":"Treatment for meibomian gland dysfunction and dry eye symptoms with a single-dose vectored thermal pulsation: a review","volume":"26","author":"Blackie","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2022.06.013_bib0015","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/ICO.0b013e318239aaea","article-title":"A new system, the LipiFlow, for the treatment of meibomian gland dysfunction","volume":"31","author":"Lane","year":"2012","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ajo.2022.06.013_bib0016","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3109\/02713683.2011.631721","article-title":"A single LipiFlow\u24c7 thermal pulsation system treatment improves meibomian gland function and reduces dry eye symptoms for 9 months","volume":"37","author":"Greiner","year":"2012","journal-title":"Curr Eye Res"},{"issue":"6","key":"10.1016\/j.ajo.2022.06.013_bib0017","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/ceo.12033","article-title":"Long-term (12-month) improvement in meibomian gland function and reduced dry eye symptoms with a single thermal pulsation treatment","volume":"41","author":"Greiner","year":"2013","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2022.06.013_bib0018","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2147\/OPTH.S234008","article-title":"Comparison of the iLUX and the LipiFlow for the treatment of meibomian gland dysfunction and symptoms: A randomized clinical trial","volume":"14","author":"Tauber","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2022.06.013_bib0019","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2147\/OPTH.S160403","article-title":"A novel system, TearCare\u24c7, for the treatment of the signs and symptoms of dry eye disease","volume":"12","author":"Badawi","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2022.06.013_bib0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2147\/OPTH.S191588","article-title":"TearCare\u24c7 system extension study: evaluation of the safety, effectiveness, and durability through 12 months of a second TearCare\u24c7 treatment on subjects with dry eye disease","volume":"13","author":"Badawi","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2022.06.013_bib0021","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/OPTO.S217639","article-title":"Intense pulsed light therapy in the treatment of meibomian gland dysfunction: current perspectives","volume":"11","author":"Giannaccare","year":"2019","journal-title":"Clin Optom (Auckl)"},{"issue":"9","key":"10.1016\/j.ajo.2022.06.013_bib0022","first-page":"527","article-title":"Evaluation of the safety and efficacy of intense pulsed light treatment with meibomian gland expression of the upper eyelids for dry eye disease","volume":"37","author":"Toyos","year":"2019","journal-title":"Photobiomodul Photomed Laser Surg"},{"issue":"4","key":"10.1016\/j.ajo.2022.06.013_bib0023","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jcjo.2016.01.005","article-title":"Outcomes of intense pulsed light therapy for treatment of evaporative dry eye disease","volume":"51","author":"Gupta","year":"2016","journal-title":"Can J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2022.06.013_bib0024","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1136\/bjo.86.12.1403","article-title":"Treatment of non-inflamed obstructive meibomian gland dysfunction by an infrared warm compression device","volume":"86","author":"Goto","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"1-2","key":"10.1016\/j.ajo.2022.06.013_bib0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40123-014-0025-8","article-title":"A randomized, controlled treatment trial of eyelid-warming therapies in meibomian gland dysfunction","volume":"3","author":"Sim","year":"2014","journal-title":"Ophthalmol Ther"},{"issue":"Suppl 2","key":"10.1016\/j.ajo.2022.06.013_bib0026","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1016\/S0039-6257(00)00201-0","article-title":"Diagnosis of dry eye","volume":"45","author":"Bron","year":"2001","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2022.06.013_bib0027","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/aos.12012","article-title":"Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications","volume":"92","author":"Sullivan","year":"2014","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2022.06.013_bib0028","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jtos.2016.09.003","article-title":"New perspectives on dry eye definition and diagnosis: a consensus report by the Asia dry eye society","volume":"15","author":"Tsubota","year":"2017","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.ajo.2022.06.013_bib0029","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.survophthal.2011.11.003","article-title":"Evaluation of dry eye","volume":"57","author":"McGinnigle","year":"2012","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2022.06.013_bib0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40123-021-00431-5","article-title":"Effect of a novel thermostatic device on meibomian gland dysfunction: a randomized controlled trial in Chinese patients","volume":"11","author":"Li","year":"2022","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"10.1016\/j.ajo.2022.06.013_bib0031","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000455087","article-title":"The limitation of applying heat to the external lid surface: a case of recalcitrant meibomian gland dysfunction","volume":"8","author":"Kenrick","year":"2017","journal-title":"Case Rep Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2022.06.013_bib0032","first-page":"278","article-title":"Comparison of a thermoelectric heat device, tea tree oil shampoo eyelid scrubs and conventional treatment in elderly patients with meibomian gland dysfunction","volume":"92","author":"Hern\u00e1ndez-Mart\u00ednez","year":"2018","journal-title":"Rev Mex Oftalmol"},{"issue":"5","key":"10.1016\/j.ajo.2022.06.013_bib0033","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the Ocular Surface Disease Index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2022.06.013_bib0034","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/ICO.0b013e318294b0c0","article-title":"Psychometric properties and validation of the Standard Patient Evaluation of Eye Dryness questionnaire","volume":"32","author":"Ngo","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2022.06.013_bib0035","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2147\/OPTH.S33588","article-title":"Comparison of ocular-surface disease index questionnaire, tearfilm break-up time, and Schirmer tests for the evaluation of the tearfilm in computer users with and without dry-eye symptomatology","volume":"6","author":"Unl\u00fc","year":"2012","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2022.06.013_bib0036","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/ICL.0000000000000544","article-title":"Ocular surface disease and glaucoma medications: a clinical approach","volume":"45","author":"Zhang","year":"2019","journal-title":"Eye Contact Lens"},{"issue":"6","key":"10.1016\/j.ajo.2022.06.013_bib0037","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/APO.0000000000000327","article-title":"Understanding the dual dilemma of dry eye and glaucoma: an international review","volume":"9","author":"Nijm","year":"2020","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"2","key":"10.1016\/j.ajo.2022.06.013_bib0038","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jcjo.2019.07.005","article-title":"Dry eye after refractive surgery: a meta-analysis","volume":"55","author":"Sambhi","year":"2020","journal-title":"Can J Ophthalmol"},{"issue":"14","key":"10.1016\/j.ajo.2022.06.013_bib0039","doi-asserted-by":"crossref","first-page":"DES109","DOI":"10.1167\/iovs.17-23538","article-title":"Dry eye after LASIK","volume":"59","author":"Toda","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2022.06.013_bib0040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4274\/tjo.galenos.2019.45538","article-title":"Dry eye disease after cataract surgery: study of its determinants and risk factors","volume":"50","author":"Garg","year":"2020","journal-title":"Turk J Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2022.06.013_bib0041","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1177\/1120672120929958","article-title":"Cataract surgery and dry eye disease: A review","volume":"30","author":"Naderi","year":"2020","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ajo.2022.06.013_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2019.11.021","article-title":"The effect of a ptosis procedure compared to an upper blepharoplasty on dry eye syndrome","volume":"212","author":"Zloto","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2022.06.013_bib0043","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/2013.jamafacial.1","article-title":"Dry eye symptoms and chemosis following blepharoplasty: a 10-year retrospective review of 892 cases in a single-surgeon series","volume":"15","author":"Prischmann","year":"2013","journal-title":"JAMA Facial Plast Surg"},{"issue":"3","key":"10.1016\/j.ajo.2022.06.013_bib0044","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II diagnostic methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul Surf"},{"issue":"12","key":"10.1016\/j.ajo.2022.06.013_bib0045","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/ICO.0b013e3182a7f3e1","article-title":"Evaluation of lipid layer thickness measurement of the tear film as a diagnostic tool for meibomian gland dysfunction","volume":"32","author":"Finis","year":"2013","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.ajo.2022.06.013_bib0046","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.ajo.2014.02.012","article-title":"Reliability of 4 clinical grading systems for corneal staining","volume":"157","author":"Sook Chun","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2022.06.013_bib0047","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jtos.2019.01.004","article-title":"Review and analysis of grading scales for ocular surface staining","volume":"17","author":"Begley","year":"2019","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.ajo.2022.06.013_bib0048","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/ICL.0b013e31811ead93","article-title":"An evaluation of the efficacy of fluorescein, rose bengal, lissamine green, and a new dye mixture for ocular surface staining","volume":"34","author":"Korb","year":"2008","journal-title":"Eye Contact Lens"},{"issue":"11","key":"10.1016\/j.ajo.2022.06.013_bib0049","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/eye.2011.184","article-title":"Optimizing evaluation of lissamine green parameters for ocular surface staining","volume":"25","author":"Hamrah","year":"2011","journal-title":"Eye (Lond)"},{"issue":"10","key":"10.1016\/j.ajo.2022.06.013_bib0050","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/ICO.0b013e3181814cff","article-title":"Meibomian gland diagnostic expressibility: correlation with dry eye symptoms and gland location","volume":"27","author":"Korb","year":"2008","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.ajo.2022.06.013_bib0051","doi-asserted-by":"crossref","first-page":"E310","DOI":"10.1097\/OPX.0b013e318244e487","article-title":"Relation between upper and lower lids' meibomian gland morphology, tear film, and dry eye","volume":"89","author":"Pult","year":"2012","journal-title":"Optom Vis Sci"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939422002525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939422002525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:51:10Z","timestamp":1757598670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939422002525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":51,"alternative-id":["S0002939422002525"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2022.06.013","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Thermoelectric Warming Therapy for the Treatment of Meibomian Gland Dysfunction","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2022.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}